Search

Your search keyword '"Suryawanshi RK"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Suryawanshi RK" Remove constraint Author: "Suryawanshi RK"
50 results on '"Suryawanshi RK"'

Search Results

1. Fibrin drives thromboinflammation and neuropathology in COVID-19.

2. The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2.

3. NF-κB inhibitor alpha controls SARS-CoV-2 infection in ACE2-overexpressing human airway organoids.

4. Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination.

5. Post-acute immunological and behavioral sequelae in mice after Omicron infection.

6. A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo.

7. Mild SARS-CoV-2 infection results in long-lasting microbiota instability.

8. Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication.

9. A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication and pathogenesis in vivo .

10. Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction.

11. Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6.

12. Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6.

13. Seropositivity of dengue cases at a tertiary care centre in Chhindwara, Madhya Pradesh: A three year trend.

14. Putative targeting by BX795 causes decrease in protein kinase C protein levels and inhibition of HSV1 infection.

15. Postinfection Metabolic Reprogramming of the Murine Trigeminal Ganglion Limits Herpes Simplex Virus-1 Replication.

16. Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2.

17. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination.

18. Limited Cross-Variant Immunity after Infection with the SARS-CoV-2 Omicron Variant Without Vaccination.

19. Viral E Protein Neutralizes BET Protein-Mediated Post-Entry Antagonism of SARS-CoV-2.

20. mTORC2 confers neuroprotection and potentiates immunity during virus infection.

21. Entry receptor bias in evolutionarily distant HSV-1 clinical strains drives divergent ocular and nervous system pathologies.

22. Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry.

23. Exo-inulinase production from Aspergillus fumigatus NFCCI 2426: purification, characterization, and immobilization for continuous fructose production.

24. Prebiotic mannooligosaccharides: Synthesis, characterization and bioactive properties.

25. Disruption of innate defense responses by endoglycosidase HPSE promotes cell survival.

26. Dysregulation of Cell Signaling by SARS-CoV-2.

27. Dissociation of DNA damage sensing by endoglycosidase HPSE.

28. Bacterial Pigment Prodigiosin Demonstrates a Unique Antiherpesvirus Activity That Is Mediated through Inhibition of Prosurvival Signal Transducers.

29. Immobilization of Aspergillus quadrilineatus RSNK-1 multi-enzymatic system for fruit juice treatment and mannooligosaccharide generation.

30. Pathological processes activated by herpes simplex virus-1 (HSV-1) infection in the cornea.

31. Production optimization and characterization of mannooligosaccharide generating β-mannanase from Aspergillus oryzae.

32. Catalytic characteristics and application of l-asparaginase immobilized on aluminum oxide pellets.

33. Extracellular red Monascus pigment-mediated rapid one-step synthesis of silver nanoparticles and its application in biomedical and environment.

34. Mechanistic approach for fabrication of gold nanoparticles by Nitzschia diatom and their antibacterial activity.

35. Fluconazole treatment enhances extracellular release of red pigments in the fungus Monascus purpureus.

36. Antimicrobial activity of prodigiosin is attributable to plasma-membrane damage.

37. Vorticella sp: Prospective Mosquito Biocontrol Agent.

38. Trypsin inactivation by latex fabricated gold nanoparticles: A new strategy towards insect control.

39. Innovative approach for urease inhibition by Ficus carica extract-fabricated silver nanoparticles: An in vitro study.

40. Mosquito larvicidal and pupaecidal potential of prodigiosin from Serratia marcescens and understanding its mechanism of action.

41. Biofunctionalized silver nanoparticles as a novel colorimetric probe for melamine detection in raw milk.

42. Bio-functionalized silver nanoparticles: a novel colorimetric probe for cysteine detection.

43. Towards an understanding of bacterial metabolites prodigiosin and violacein and their potential for use in commercial sunscreens.

44. Phytolatex synthesized gold nanoparticles as novel agent to enhance sun protection factor of commercial sunscreens.

45. Mercury sensing and toxicity studies of novel latex fabricated silver nanoparticles.

46. Transformation of aromatic dyes using green synthesized silver nanoparticles.

47. Catalytic and synergistic antibacterial potential of green synthesized silver nanoparticles: Their ecotoxicological evaluation on Poecillia reticulata.

48. Studies on production and biological potential of prodigiosin by Serratia marcescens.

49. Mosquito Larvicidal Potential of Gossypium hirsutum (Bt cotton) Leaves Extracts against Aedes aegypti and Anopheles stephensi larvae.

50. Ficus carica latex-mediated synthesis of silver nanoparticles and its application as a chemophotoprotective agent.

Catalog

Books, media, physical & digital resources